Revance Therapeutics, Inc.
Revance Therapeutics, Inc. (RVNC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RVNC · as of Jun 10, 2026
Key Statistics
Explore Revance Therapeutics, Inc. Data
rvnc stock data · financialsAbout Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company specializing in the research, manufacturing, and marketing of neuromodulators for diverse aesthetic and therapeutic uses across both domestic and …
what is revance therapeutics, inc. · rvnc stock overview · revance therapeutics, inc. company profile · who is revance therapeutics, inc. ceo · rvnc NASDAQ · revance therapeutics, inc. headquarters · revance therapeutics, inc. business segments
About Stock Overview & Key Data
Revance Therapeutics, Inc. (RVNC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 6, 2014. As of the latest trading session, RVNC stock price is $3.65, with a market capitalization of $381.0M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Revance Therapeutics, Inc. (RVNC) stock price is $3.65. The stock is traded on NASDAQ under the ticker symbol RVNC. The 52-week range is $2.30 – $7.56.